Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sostek

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Developmental Psychobiology|July 1, 1976
Stability of motor OR and heart rate habituation rates of infancyA M Sostek, Y Brackbill
Child Development|March 1, 1977
Relationships among the Brazelton Neonatal Scale, Bayley Infant Scales, and early temperamentA M Sostek, T F Anders
Child Development|December 1, 1975
Effects of varying laboratory conditions on behavioral-state organization in two- and eight-week-old infantsA M Sostek, T F Anders
Applied Research in Mental Retardation|January 1, 1984
Use of time-lapse video recording for the direct measurement of behavior in the mentally retardedT R Linscheid, J Feiner, A M Sostek
CPT: Pharmacometrics & Systems Pharmacology|June 15, 2016
Simulation and Prediction of the Drug-Drug Interaction Potential of Naloxegol by Physiologically Based Pharmacokinetic ModelingD Zhou, K Bui, M Sostek, et al.
Psychosomatic Medicine|July 1, 1976
Diuranal rhythms in 2- and 8-week-old infants: sleep-waking state organization as a function of age and stressA M Sostek, T F Anders, A J Sostek
Alimentary Pharmacology & Therapeutics|February 16, 2005
Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitisM B Fennerty, J F Johanson, C Hwang, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2010
Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteersP Miner, J Plachetka, E Orlemans, et al.
Child Development|June 1, 1987
Developmental outcome of preterm infants with intraventricular hemorrhage at one and two years of ageA M Sostek, Y F Smith, K S Katz, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2005
Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro-oesophageal reflux diseaseD C Metz, P B Miner, D M Heuman, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Developmental Psychobiology|July 1, 1976
Stability of motor OR and heart rate habituation rates of infancyA M Sostek, Y Brackbill
Child Development|March 1, 1977
Relationships among the Brazelton Neonatal Scale, Bayley Infant Scales, and early temperamentA M Sostek, T F Anders
Child Development|December 1, 1975
Effects of varying laboratory conditions on behavioral-state organization in two- and eight-week-old infantsA M Sostek, T F Anders
Applied Research in Mental Retardation|January 1, 1984
Use of time-lapse video recording for the direct measurement of behavior in the mentally retardedT R Linscheid, J Feiner, A M Sostek
CPT: Pharmacometrics & Systems Pharmacology|June 15, 2016
Simulation and Prediction of the Drug-Drug Interaction Potential of Naloxegol by Physiologically Based Pharmacokinetic ModelingD Zhou, K Bui, M Sostek, et al.
Psychosomatic Medicine|July 1, 1976
Diuranal rhythms in 2- and 8-week-old infants: sleep-waking state organization as a function of age and stressA M Sostek, T F Anders, A J Sostek
Alimentary Pharmacology & Therapeutics|February 16, 2005
Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitisM B Fennerty, J F Johanson, C Hwang, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2010
Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen/esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg: a randomized, open-label, Phase I study in healthy volunteersP Miner, J Plachetka, E Orlemans, et al.
Child Development|June 1, 1987
Developmental outcome of preterm infants with intraventricular hemorrhage at one and two years of ageA M Sostek, Y F Smith, K S Katz, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2005
Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro-oesophageal reflux diseaseD C Metz, P B Miner, D M Heuman, et al.
Pageof 2